Latest Regulatory News

Bio-Gene Technology reports significant progress in developing its bio-insecticides Flavocide and Qcide, including new efficacy data and organic certification, positioning the company for growth amid rising global demand for safer pest control.

Bass Oil Limited reported a 32% jump in October sales revenue alongside a 4% rise in daily production, while advancing its strategic Vanessa gas field acquisition targeting first gas sales in the second half of 2026.

Nufarm’s FY25 results reveal robust growth in crop protection and a strategic reset in seed technologies, with a significant reduction in net debt setting the stage for a stronger FY26.

Nufarm Limited posted a $165.3 million statutory loss for FY25, driven by significant restructuring charges and omega-3 price declines, while announcing a CEO transition effective January 2026.

LGI Limited reported robust FY25 results, expanding electricity capacity by 44% and increasing EBITDA by 14%, driven by new landfill gas contracts and battery storage projects. The company is well positioned to capitalize on Australia’s renewable energy transition and evolving carbon credit market.

White Energy Company Limited has launched a $3.5 million entitlement offer to fund exploration across its copper projects, with drilling already underway at the Specimen Hill site in Queensland. The company is leveraging AI and advanced geophysics to target high-grade copper zones, aiming for a near-term discovery.

Dimerix Limited’s ACTION3 Phase 3 trial for DMX-200 in FSGS kidney disease has passed its seventh Independent Data Monitoring Committee review with no safety concerns, reinforcing the drug’s promising safety profile.

Horizon Oil Limited reported robust FY25 results, highlighted by a strategic acquisition of Thailand upstream assets and a 10-year permit extension at Maari, nearly doubling production and securing a strong outlook through 2030.

Prescient Therapeutics has achieved a key regulatory milestone with the European Medicines Agency granting Orphan Drug Designation for its PTX-100 therapy targeting Cutaneous T-cell Lymphomas, enhancing its commercial and clinical prospects in Europe.

Red Mountain Mining Ltd has made a strong entrance on the US OTCQB market, surging 36% on its first day of trading as it advances key antimony and gold projects across the US and Australia.

Middle Island Resources has identified significant lead and zinc soil anomalies at the Tisovik target within its Bobija Project in Serbia, highlighting promising exploration potential in a historically mined area. Assay results reveal high-grade mineralisation footprints extending over 1.5km, setting the stage for further investigation.

Talga Group has received official land allocation approval for its Nunasvaara Södra graphite mine in Sweden, a critical step in advancing its sustainable battery materials project.